Related Experiment Video
Updated: Sep 15, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
1-Year Outcomes of Transcatheter Arterialization of Deep Veins: PROMISE II and Pooled PROMISE Studies
Mehdi H Shishehbor1, Hany Zayed2, Anahita Dua3
1University Hospitals Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.
Insights
Transcatheter arterialization of the deep veins (TADV) offers hope for chronic limb-threatening ischemia (CLTI) patients ineligible for conventional treatments. The LimFlow System demonstrated durable limb salvage and improved symptoms at one year in a large patient cohort.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Regenerative Medicine
Background:
- Chronic limb-threatening ischemia (CLTI) affects up to 20% of patients who are ineligible for traditional revascularization.
- These
- no-option
Purpose of the Study:
- To evaluate the 1-year outcomes of transcatheter arterialization of the deep veins (TADV) using the LimFlow System in patients with CLTI.
- To present findings from the PROMISE II trial and a pooled analysis of PROMISE I, II, and UK studies.
Main Methods:
- A single-arm, multicenter prospective study (PROMISE II) included patients with Rutherford class 5/6 CLTI.
- Outcomes assessed included amputation-free survival (AFS), limb salvage, survival, Rutherford classification, pain scores, and wound healing at 1 year.
Main Results:
- In PROMISE II (105 patients), 1-year AFS was 54.2%, limb salvage was 68.7%, and survival was 79.0%.
- The pooled analysis (137 patients) showed 1-year AFS of 66.1%, limb salvage of 74.4%, and survival of 88.9%.
- Clinical symptoms and wound healing improved through 1 year.
Conclusions:
- Transcatheter arterialization of the deep veins (TADV) with the LimFlow System provides durable amputation-free survival and limb salvage in no-option CLTI patients.
- The procedure also led to significant improvements in clinical symptoms and wound healing.
- TADV represents a viable option for CLTI patients facing high amputation or palliative care rates.
Background:
Up to 20% of patients with chronic limb-threatening ischemia (CLTI) are ineligible or have exhausted conventional options of lower extremity revascularization ("no-option") and face high rates of major amputation and death.
Objectives:
The authors present the 1-year outcomes of the pivotal PROMISE II trial and a patient-level pooled analysis combined with PROMISE I and PROMISE UK, comprising the largest cohort of prospectively studied patients following transcatheter arterialization of the deep veins (TADV) with the LimFlow System.
Methods:
The single-arm, multicenter prospective PROMISE II study included patients with Rutherford class 5/6 CLTI and independently assessed no-option status. Amputation-free survival (AFS), limb salvage, and survival were assessed through 1 year. Clinical outcomes included Rutherford classification, pain scores, and wound healing.
Results:
In PROMISE II, 105 enrolled patients had a median age of 70 years, 68.6% (72/105) were men, and the prevalence of comorbidities was high, including 77.1% (81/105) with diabetes. At 1 year, AFS was 54.2% (95% CI: 45.2-65.1%), limb salvage was 68.7% (95% CI: 59.8-78.9%), and survival was 79.0% (95% CI: 70.2-88.8%). The pooled analysis included 137 patients from PROMISE I, II, and UK and showed 1-year AFS of 66.1% (95% CI: 58.4-74.9%), limb salvage of 74.4% (95% CI: 67.1-82.5%), and survival of 88.9% (95% CI: 82.9-95.2%). Clinical symptoms and wound status showed improvement through 1 year.
Conclusions:
1-year outcomes following TADV with the LimFlow System demonstrated durable AFS and limb salvage rates, and improvement in clinical symptoms in no-option CLTI patients who often face major amputation or palliative care.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Hemodialysis I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

